EUVIMEDEUVIMED entdecken
Crossref

Preliminary Report Examining Efficacy and Safety of Radiofrequency Ablation for the Treatment of Skin-Involving Recurrent Thyroid Cancer

Hye Hyeon Moon, Jung Hwan Baek, Sae Rom Chung, Young Jun Choi, Ki-Wook Chung, Tae Yong Kim, Jeong Hyun Lee

Thyroid® · 2025

DOI: 10.1089/thy.2024.0339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thyroid®, 2025. Verfasst von Hye Hyeon Moon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Research institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Radiofrequency Ablation, Neoplasm Recurrence, Local, Skin Neoplasms. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study assessed the efficacy and safety of ultrasound (US)-guided radiofrequency ablation (RFA) for treatment of skin-involving recurrent thyroid cancer.

Methods

In this retrospective case series study, 43 patients (mean age: 67.9 ± 14.4 years; 31 females) with skin-involving recurrent thyroid cancer were treated with RFA for a total of 50 tumors between May 2008 and March 2023. The location of the tumor was classified into epidermis, dermis, or hypodermis on the basis of the involved skin layer. After RFA, the technique efficacy (absence of detectable vasculature and volume reduction at 12 months), clinical success (resolution of symptoms or cosmetic problems), volume reduction ratio (VRR), complete disappearance of tumor, and complications were assessed.

Results

Of the 50 recurrent tumors, 9 involved the epidermis, 10 involved the dermis, and 31 involved the hypodermis. A total of 88 RFA sessions (mean, 1.8; range: 1-6) were performed. The technique efficacy at 1 year was 72% (36/50 [confidence interval or CI: 59.6-84.4%]). At the last follow-up (median [interquartile range]: 2.7 [1.1-4.5] years), the clinical success rate was 86% (44/50), the complete disappearance rate 54% (27/50), and the mean VRR 77.3% ± 44.2%. In a subgroup analysis comparing epidermis/dermis vs. hypodermis, there was no statistical difference in technique efficacy (57.9% [11/19] vs. 80.6% [25/31], p = 0.085), clinical success rate (78.9% [15/19] vs. 90.3% [28/31], p = 0.265), complete disappearance rate (42.1% [8/19] vs. 51.6% [16/31], p = 0.541), or mean VRR (65.5% vs. 84.6%, p = 0.141). Skin burns were observed in 4.9% per treatment session (2/41 [CI: 0-11.3%]) of epidermis/dermis-involving tumor procedures and none of the hypodermal tumor procedures. No patients experienced life-threatening or major complications.

Conclusions

RFA might serve as a promising approach for managing skin-involving recurrent thyroid cancer, with no major complications reported in this preliminary study. Recurrent tumors involving the epidermis/dermis may pose a higher risk of skin burns than tumors involving the hypodermis. Early intervention with RFA before the tumor extends to the epidermis/dermis may thus be preferable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsRadiofrequency AblationNeoplasm Recurrence, LocalSkin NeoplasmsHumansFemaleMaleAgedMiddle AgedRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

radiofrequency ablationrecurrent thyroid cancerskinthyroidultrasound

Autor:innen und Institutionen

  • Department of Radiology and Research institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Division of Endocrinology & Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Zitieren

APA

Moon, H. H., Baek, J. H., Chung, S. R., Choi, Y. J., Chung, K. W., Kim, T. Y., & Lee, J. H. (2025). Preliminary Report Examining Efficacy and Safety of Radiofrequency Ablation for the Treatment of Skin-Involving Recurrent Thyroid Cancer. Thyroid®. https://doi.org/10.1089/thy.2024.0339

Vancouver

Moon HH, Baek JH, Chung SR, Choi YJ, Chung KW, Kim TY, et al. Preliminary Report Examining Efficacy and Safety of Radiofrequency Ablation for the Treatment of Skin-Involving Recurrent Thyroid Cancer. Thyroid®. 2025. doi:10.1089/thy.2024.0339

BibTeX
@article{Moon2025,
  author = {Moon, Hye Hyeon and Baek, Jung Hwan and Chung, Sae Rom and Choi, Young Jun and Chung, Ki-Wook and Kim, Tae Yong and Lee, Jeong Hyun},
  title = {Preliminary Report Examining Efficacy and Safety of Radiofrequency Ablation for the Treatment of Skin-Involving Recurrent Thyroid Cancer},
  journal = {Thyroid®},
  year = {2025},
  doi = {10.1089/thy.2024.0339}
}
Kostenlos starten →